CareDx Announces Clinical Validation Results for AlloHeme, the First AIPowered NGS Surveillance Solution for AML and MDS PostCell Therapy
CareDx, Inc. (Nasdaq: CDNA) The Transplant Company, a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, highvalue...